Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Ibudilast

EU orphan designation number: EU/3/16/1801   
Active ingredient: Ibudilast
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: MediciNova (Europe) Limited
12 New Fetter Lane, London EC4A 1JP, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/12/2016 Orphan designation EMA/OD/182/16 (2016)8701 of 12/12/2016